生命科学资讯

Cancer blood test developer Freenome to go public in $330M SPAC deal

Biopharma sentiment hit a turning point in October

OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio

Hemophilia gene therapies are struggling on the market, even as innovation soars

ACIP continues to struggle with HBV vaccine scheduling

Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use

Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga

Adaptive communication between cell assemblies and “reader” neurons shapes flexible brain dynamics

The transcription factor SKN-1 drives lysosomal enlargement during aging to maintain function

Correction: Catecholamines reduce choice history biases in perceptual decision making

Laigo raises €11.5M seed money for targeted protein degradation

FDA conflicts of interest extend beyond adcomm experts

New FGFR3 inhibitors disclosed in Onco3r Therapeutics patent

Synnovation Therapeutics discovers new NRF2 inhibitors

Holiday notice

Knuff & Co LLC Sells 3,559 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Illumina (NASDAQ:ILMN) Upgraded at Zacks Research - MarketBeat

German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme

Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability

Ex-Intercept CEO takes over at Altimmune; Carolyn Bertozzi leaves Alnylam's board